Clinical trial
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia…
NCT00055653 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00055653 |
|---|---|
| Title | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders |
| Official title | Unrelated Umbilical Cord Blood As An Alternate Source Of Stem Cells Transplantation |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, filgrastim, busulfan, cyclophosphamide, cyclosporine, fludarabine phosphate, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Mar 7, 2003 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: